Published in Gene Therapy Weekly, January 7th, 2010
"The primary objective of the study was to determine the importance of Smad4 in TGF beta 2-induced transdifferentiation, matrix contraction, and Smad signaling by human lens epithelial cells. The human lens cell line FHL 124 was used. Smad4 knockdown was achieved by using siRNA technology and efficiency...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.